extraordinary people, extraordinary outcomes 1 confidential september, 30 th 2014 a conversation...

5
traordinary People, Extraordinary Outcomes 1 Confidential September, 30 th 2014 A Conversation with Edward Kaye www.novuslife.com

Upload: cameron-caldwell

Post on 19-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Extraordinary People, Extraordinary Outcomes 1 Confidential September, 30 th 2014 A Conversation with Edward Kaye

Extraordinary People, Extraordinary Outcomes

1Confidential

September, 30th 2014

A Conversation with Edward Kaye

www.novuslife.com

Page 2: Extraordinary People, Extraordinary Outcomes 1 Confidential September, 30 th 2014 A Conversation with Edward Kaye

2Confidentialwww.novuslife.com

Supporting Studies:

HEOR, etc.

Regulatory Approval

Pre IND Phase

Phase I – II Clinical Trials

Phase III – IIIb Clinical Trials

Pharmacovigilance / Post- Marketing Commitments /Phase IV Clinical Trials / Registry

NovusLife, among other services, is helping companies compile the required clinical evidence from the very beginning of their clinical development programs. We believe that this is crucial for firms such as Sarepta.

Page 3: Extraordinary People, Extraordinary Outcomes 1 Confidential September, 30 th 2014 A Conversation with Edward Kaye

3

Why NovusLife?The consultants at NovusLife can help you design and implement the strategies and programs to build the clinical evidence required to support the development and launch of your drug (or device) product.

Benefits to clients:• We are part of your team.

You keep full control over your projects, meet your timeline and budget milestones, and achieve your corporate goals.

• We help you create an efficient roadmap toward the approval, launch, and optimal uptake of your new product.

Engage the appropriate stakeholders early and often to identify and gather the most important clinical evidence.

Set the guardrails within which your research vendors (e.g. CROs, EDC, etc.) operate. Anticipate emerging issues and possible detours along the clinical development path and

apply the right solutions.

• We can lead clinical development projects from inception through completion – or support specific steps in-between based on your requirements.

Ensure continuity of goals and action plans among your vendors and stakeholders along the research path.

Avoid the pitfalls of missed opportunities.

Page 4: Extraordinary People, Extraordinary Outcomes 1 Confidential September, 30 th 2014 A Conversation with Edward Kaye

4

Why NovusLife? We need a differentiator slide.

Confidentialwww.novuslife.com

Page 5: Extraordinary People, Extraordinary Outcomes 1 Confidential September, 30 th 2014 A Conversation with Edward Kaye

Phone:

781-790-8145

Fax:

781-996-3676

www.novuslife.com

Address:

NovusLife, LLC1344 Main StreetWaltham, MA 02451

Email:

[email protected]@[email protected]